BioTeam

Executive Summary

BioTeam is a privately held scientific IT consulting firm headquartered in Cambridge, Massachusetts, with over two decades of experience at the intersection of science, data, and technology. Founded in 2002, the company specializes in closing the gap between what scientists aspire to achieve with data and what they can practically accomplish, leveraging expertise in AI/ML and digital health. BioTeam serves the life sciences and healthcare sectors, offering consulting services that span bioinformatics, data management, cloud infrastructure, and custom software development. Despite being a private entity with no disclosed funding rounds or valuation, its long-standing presence and focus on high-value, niche services suggest a stable, likely profitable operation. The company benefits from the accelerating digitization of R&D in pharma and biotech, positioning it to capitalize on growing demand for data-driven insights and AI-enabled workflows. However, as a consulting firm, its growth is tied to project-based revenue and client retention rather than scalable product sales, which may limit its upside compared to technology platform companies. BioTeam’s deep domain expertise and reputation in the scientific community provide a competitive moat, but the fragmented consulting landscape and potential margin pressures from larger IT firms present ongoing challenges. Overall, BioTeam represents a resilient, specialized player in the scientific IT consulting space with moderate growth prospects tied to industry tailwinds.

Upcoming Catalysts (preview)

• Q3 2026Expansion of AI/ML Consulting Services for Drug Discovery70% success
• Q2 2026Strategic Partnership with a Major Pharmaceutical Company50% success
• TBDAcquisition by a Larger IT or Consulting Firm40% success